Shopping Cart
- Remove All
- Your shopping cart is currently empty
ALLM (Calpain inhibitor II), a potent calpain and cathepsin protease inhibitor, not only prevents neuronal cell death but also enhances chronic neurological function following spinal cord injury (SCI)[1][2].
Description | ALLM (Calpain inhibitor II), a potent calpain and cathepsin protease inhibitor, not only prevents neuronal cell death but also enhances chronic neurological function following spinal cord injury (SCI)[1][2]. |
In vivo | ALLM (Calpain inhibitor II) (0.5 mg/kg) is administered every 24 hours for 5 days following spinal cord injury (SCI), inhibiting calpain activation without affecting caspase 3. ALLM (0.05-2.5 mg/kg; i.p.; every 24 hours for 1 week) reduces motor disturbances post-SCI and prevents neuronal cell death[2]. |
Alias | Calpain inhibitor II |
Molecular Weight | 401.56 |
Formula | C19H35N3O4S |
Cas No. | 110115-07-6 |
Relative Density. | 1.076 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.